Wound Care Medical Necessity Letter: Template and Guidance
How to write medical necessity statements for wound care skin substitutes, NPWT, and HBOT — what payers and MACs expect and template language.
Damon Ebanks
Medipyxis

Wound Care Medical Necessity Letter Template
The medical necessity statement is the document that separates a paid claim from a denied one. It's the clinical narrative that explains -- in language the payer's medical reviewer can follow -- why this patient needed this specific treatment at this specific point in their care. Not "wound care is generally beneficial" but "this wound, in this patient, with this documented history, required this intervention because conservative treatment failed in this documented way."
Most wound care denials cite CO-50: not deemed medically necessary. In practice, that usually doesn't mean the treatment wasn't necessary. It means the documentation didn't make the case clearly enough for the reviewer to approve it. The medical necessity statement is where you make that case.
This guide covers the structure and language for medical necessity letters supporting skin substitutes, negative pressure wound therapy (NPWT), and hyperbaric oxygen therapy (HBOT). For LCD-specific compliance requirements, see Wound Care LCD Compliance. For prior authorization workflows, see Wound Care Prior Authorization Guide.
Core Structure: Every Medical Necessity Letter
Regardless of the treatment type, every wound care medical necessity letter follows the same framework.
Patient and Wound Identification
Open with the clinical context. The reviewer needs to orient themselves before they evaluate your argument.
"Patient [name], DOB [date], MBI [number], presents with a [wound type] of the [anatomical location]. The wound was first identified on [date] with an initial presentation of [dimensions] cm. The wound etiology has been determined to be [etiology] based on [clinical findings, diagnostic results]."
Include relevant comorbidities that affect wound healing: diabetes (with most recent HbA1c), peripheral vascular disease (with ABI results), immunocompromise, nutritional deficiency, or chronic venous insufficiency. These aren't filler -- they establish why this wound requires more than standard care.
Conservative Treatment History
This section is where most medical necessity arguments succeed or fail. The LCD requires documented evidence that conservative treatment was attempted and failed before advanced therapies are considered medically necessary.
"Conservative wound management was initiated on [date] and continued through [date], encompassing [X] weeks of treatment. Interventions included [specific dressing types, offloading strategies, compression therapy, nutritional optimization, glycemic management]. Serial wound measurements documented the following progression:"
Include a measurement table:
| Date | L x W x D (cm) | Area (sq cm) | Change from Prior |
|---|---|---|---|
| [Date 1] | [measurements] | [area] | Baseline |
| [Date 2] | [measurements] | [area] | [+/- %] |
| [Date 3] | [measurements] | [area] | [+/- %] |
"Despite [X] weeks of consistent conservative management with documented compliance, the wound demonstrated [less than 30% reduction in area / no measurable improvement / increase in wound area], indicating failure of conservative treatment as defined by LCD [L-number]."
Medical Necessity Rationale
State the clinical reasoning for the specific treatment. Connect the dots between wound status, treatment failure, and the requested intervention.
"Based on the documented failure of conservative treatment, the clinical characteristics of the wound bed, and the patient's overall medical status, [treatment name] is medically necessary to [promote wound closure / prevent limb loss / manage wound exudate / stimulate tissue granulation]."
Treatment-Specific Language
The rationale language differs by treatment category. Use the sections below as templates.
Skin Substitute Medical Necessity
Skin substitute claims are the most frequently denied wound care service category. The medical necessity statement needs to address every LCD criterion.
Key elements to document:
- Wound has failed to respond to at least 30 days of conservative treatment with documented measurements showing <30% area reduction
- Wound bed is free of necrotic tissue (or debridement was performed to prepare the wound bed)
- No clinical signs of uncontrolled wound infection
- Adequate blood supply to the wound area, confirmed by vascular assessment (ABI >0.5 for lower extremity wounds, or documented clinical assessment)
- The specific product selected is appropriate for the wound type and location
Template language: "The wound bed has been prepared through [selective/non-selective] debridement performed on [date], achieving a clean, granulating wound base suitable for graft application. Vascular assessment performed on [date] confirmed [adequate perfusion / ABI of X.XX]. There are no clinical signs of wound infection. Based on the wound's failure to progress under conservative management and the current wound bed characteristics, application of [product name, Q-code] is medically necessary to promote wound closure. The product was selected based on [wound size, depth, location, tissue type] consistent with the product's FDA-cleared indications."
NPWT Medical Necessity
Negative pressure wound therapy requires documentation of wound characteristics that make NPWT the appropriate treatment modality.
Key elements to document:
- Wound type is appropriate for NPWT (chronic wounds, acute traumatic wounds, dehisced surgical wounds, partial-thickness burns, skin graft sites)
- Wound has adequate depth for NPWT application (typically >2 cm depth or with undermining/tunneling)
- Patient is compliant with NPWT requirements (or has caregiver support)
- No contraindications present (exposed blood vessels, malignancy in the wound, untreated osteomyelitis, non-enteric unexplored fistulae)
Template language: "The patient's [wound type] of the [location] measures [L x W x D] cm with [undermining/tunneling] at [clock position]. The wound bed demonstrates [granulation tissue / wound exudate volume requiring management]. NPWT is medically necessary to [manage wound exudate, promote granulation tissue formation, reduce wound volume, prepare the wound bed for definitive closure]. The wound meets criteria for NPWT as defined by LCD [L-number]: [cite specific criteria met]. There are no contraindications to NPWT application. The patient [has been educated on device management / has caregiver support for device management]."
HBOT Medical Necessity
Hyperbaric oxygen therapy has the most stringent medical necessity requirements. The documentation must establish that the wound meets specific diagnostic criteria and that prior treatments have been exhausted.
Key elements to document:
- Wound meets a covered diagnosis (diabetic lower extremity wound, chronic refractory osteomyelitis, compromised skin graft, soft tissue radionecrosis)
- For diabetic wounds: Wagner grade III or higher, adequate vascular status, glycemic optimization documented
- Failure of standard wound care for at least 30 days
- No contraindications (untreated pneumothorax, certain medications)
- Treatment plan includes concurrent wound care, not HBOT as standalone therapy
Template language: "The patient's diabetic [wound type] of the [location] is classified as Wagner Grade [III/IV/V]. Despite [X] weeks of comprehensive wound management including [offloading, glycemic management (HbA1c: [X.X%]), debridement, moist wound therapy, vascular optimization], the wound has failed to demonstrate measurable healing progress. HBOT is medically necessary as adjunctive therapy to promote tissue oxygenation and support wound healing in the context of diabetes-related microvascular compromise. Transcutaneous oxygen measurement (TCOM) performed on [date] demonstrated [periwound values], supporting the clinical indication for HBOT. The patient will continue concurrent wound care management during the HBOT treatment course."
What Makes the Difference
The medical necessity statements that get approved share three characteristics.
They're specific, not generic. "The wound requires advanced treatment" gets denied. "The wound failed to reduce by more than 12% over 6 weeks of conservative management including [specific treatments], and the wound bed now demonstrates characteristics suitable for [specific treatment]" gets approved.
They reference the LCD explicitly. Don't make the reviewer look up the criteria. "This treatment meets the criteria established by LCD [L-number], specifically: [criterion 1 -- met, documented on date], [criterion 2 -- met, documented on date]."
They include the measurement trajectory. A table of wound measurements across visits tells the wound's story more convincingly than any narrative paragraph. Stable or increasing wound area after conservative treatment is the single strongest piece of evidence for medical necessity of advanced wound care.
Key Takeaways
- Structure the letter with patient identification, wound history, conservative treatment timeline, clinical rationale for advanced therapy, and explicit LCD criteria crosswalk
- Include a wound measurement progression table showing dimensions across visits -- this single element is more persuasive than any narrative paragraph
- Reference the specific LCD by number and section, connecting each documentation element to the corresponding coverage criterion
- Write for the reviewer who will read dozens of these letters in a day: clear, factual, organized, and free of defensive or argumentative language